Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: December 9, 2008
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2016
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)